$50 Billion Regenerative Medicines Market, 2025

The regenerative medicines market generated $17.03 billion revenue in 2016 and is expected to reach $50.55 billion by 2025

The North America regenerative medicines market currently holds 39% percent of the global regenerative medicines market. Technological innovations across the various segments of the regenerative medicine have propelled growth in the recent past in the region.

Regenerative medicine presents with opportunities to change the treatment options, and offers complete cure of the diseases. The pharmaceutical industry is witnessing the growth of pipeline of candidates for regenerative medicine. A number of companies are now indulging in the research and development of such therapies.

The regenerative medicine market includes various cellular, and acellular products. The market involves various therapies such as gene therapy, cell therapy, and tissue engineering. This therapy is being applied to a number of diseases, and therapeutic areas such as orthopaedic, cardiovascular, wound healing, diabetes, neurodegenerative, immune-oncology, and others. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.

This research report aims at answering various aspects of the global regenerative medicine market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global regenerative medicine market, and assesses the factors governing the same.

The answers to the following key questions can be derived from this report:

The key players that have been contributing significantly to the regenerative medicine market are Novartis AG, ViaCyte, Inc., Vericel Corporation, Tissue Regenix, Osiris Therapeutics, Inc., NuVasive, Inc., MiMedx Group Inc., Mesoblast Limited, Acelity, and Cytori Therapeutics, among others.

Key Topics Covered:

Executive Summary

1 Report Scope
1.1 Scope of the Report
1.2 Global Regenerative Medicine Market Segmentation
1.3 Research Methodology

2 Market Overview
2.1. Introduction
2.2. Evolutionary History
2.3. Present And Future

3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

4 Competitive Landscape
4.1. Share of Key Developments & Strategies
4.2. Market Share Analysis
4.3. Porter's Five Force Analysis

5 Global Regenerative Medicines Market, by Therapy
5.1. Cell Therapy
5.2. Gene Therapy
5.3. Tissue Engineering

6 Global Regenerative Medicines Market, by Product (Qualitative)
6.1. Introduction
6.2. Acellular Products
6.3. Cellular Products
6.4. Products
6.5. Pipeline Products

7 Global Regenerative Medicines Market, by Application
7.1. Introduction
7.2. Orthopaedic & Dental
7.3. Cardiology
7.4. Wound Healing
7.5. Diabetes
7.6. Immuno-Oncology
7.7. Others

8 Global Regenerative Medicines Market, by Region
8.1. Introduction
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/lg4xgz/50_billion?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716